A Phase 2b, Randomized, Double-Blind, Saline Placebo- and Active-Controlled, Multicenter Study of HTX-011 Via Infiltration for Postoperative Analgesia in Subjects Undergoing Total Knee Arthroplasty
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Bupivacaine/meloxicam (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Pharmacokinetics
- Sponsors Heron Therapeutics
- 29 Sep 2017 Planned number of patients changed from 120 to 160.
- 29 Sep 2017 Planned End Date changed from 1 Nov 2017 to 1 Apr 2018.
- 29 Sep 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Mar 2018.